Vaccines Press Releases

Phinge Corporation, the innovator behind the upcoming patented, app-less Netverse® platform, today announced that its technology is poised to revolutionize the clinical trial landscape.

According to the latest report published by DPI Research, The global influenza vaccines market size was valued at USD 7.8 Billion in 2023 and is likely to reach USD 13.7 Billion in 2032, expanding at a CAGR 7.2% during the forecast period.